Clinical Trial Update: Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of romiplostim in adults with persistent or chronic immune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Kyowa Kirin China Pharmaceutical Co., Ltd. | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED